Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences
WASHINGTON, Nov. 12, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in November 2024:
华盛顿,2024 年 11 月 12 日 /PRNewswire/ — 万达制药公司(Vanda)(纳斯达克: VNDA)今天宣布,该公司将参加以下即将在2024年11月举行的投资者会议:
The Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024. A corporate presentation is scheduled for 9:45 a.m. Eastern Time.
Stifel 2024 医疗保健会议将于 2024 年 11 月 19 日星期二举行。公司演讲定于美国东部时间上午 9:45 举行。
The Jefferies 2024 London Healthcare Conference on Thursday, November 21, 2024. A fireside chat is scheduled for 11:30 a.m. Greenwich Mean Time (6:30 a.m. Eastern Time).
杰富瑞2024年伦敦医疗保健会议将于2024年11月21日星期四举行。炉边谈话定于格林威治标准时间上午 11:30(美国东部时间上午 6:30)举行。
The corporate presentation and fireside chat given at the Stifel and Jefferies conferences, respectively, may be accessed live on Vanda's corporate website, . Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.
分别在Stifel和Jefferies会议上进行的公司演讲和炉边谈话可以在Vanda的公司网站上现场直播。投资者应单击 “投资者” 选项卡,然后点击 “近期事件” 下的链接。建议投资者至少提前15分钟访问会议网站进行注册、下载和安装任何必要的软件或演示文稿。存档会议的链接将在Vanda的网站上提供,为期约30天。
About Vanda Pharmaceuticals Inc.
关于万达制药公司
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit and follow us on X @vandapharma.
Vanda是一家领先的全球生物制药公司,专注于创新疗法的开发和商业化,以满足大量未满足的医疗需求并改善患者的生活。有关 Vanda Pharmicals Inc. 的更多信息,请访问并在 X @vandapharma 上关注我们。
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
[email protected]
公司联系人:
凯文·莫兰
高级副总裁、首席财务官兼财务主管
万达制药公司
202-734-3400
[电子邮件保护]
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
[email protected]
吉姆·戈尔登/杰克·凯勒赫/丹·摩尔
收集的策略
[电子邮件保护]
SOURCE Vanda Pharmaceuticals Inc.
来源 Vanda 制药公司